Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERIORINSE in Gingival Inflammation
NCT00885599Phase 2Completed
- Sponsor
- Shaare Zedek Medical Center
- Start
- Jun 2009
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of PeriActive in gingivitis (4 arms), sponsored by Shaare Zedek Medical Center. Primary endpoint: Gingival Index at 14 days. Started Jun 2009; status: completed.
02
Drugs
PeriActive
03
Conditions
gingivitis
Beyond the preview
Go deeper on NCT00885599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00885599.